全文获取类型
收费全文 | 275篇 |
免费 | 19篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 16篇 |
妇产科学 | 4篇 |
基础医学 | 45篇 |
口腔科学 | 1篇 |
临床医学 | 30篇 |
内科学 | 36篇 |
皮肤病学 | 9篇 |
神经病学 | 16篇 |
特种医学 | 5篇 |
外科学 | 30篇 |
综合类 | 4篇 |
预防医学 | 44篇 |
药学 | 29篇 |
中国医学 | 11篇 |
肿瘤学 | 15篇 |
出版年
2022年 | 5篇 |
2021年 | 4篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 8篇 |
2017年 | 6篇 |
2016年 | 3篇 |
2015年 | 5篇 |
2014年 | 5篇 |
2013年 | 10篇 |
2012年 | 14篇 |
2011年 | 13篇 |
2010年 | 4篇 |
2009年 | 11篇 |
2008年 | 10篇 |
2007年 | 13篇 |
2006年 | 15篇 |
2005年 | 23篇 |
2004年 | 7篇 |
2003年 | 26篇 |
2002年 | 6篇 |
2001年 | 12篇 |
2000年 | 11篇 |
1999年 | 8篇 |
1998年 | 7篇 |
1997年 | 4篇 |
1995年 | 3篇 |
1994年 | 3篇 |
1992年 | 5篇 |
1991年 | 4篇 |
1990年 | 5篇 |
1987年 | 3篇 |
1986年 | 4篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1973年 | 1篇 |
1972年 | 5篇 |
1971年 | 1篇 |
1970年 | 2篇 |
1969年 | 2篇 |
1967年 | 1篇 |
1941年 | 1篇 |
1940年 | 1篇 |
排序方式: 共有295条查询结果,搜索用时 15 毫秒
291.
Endomorphin-1 is a novel endogenous opioid peptide with high affinity and selectivity for the mu-opioid receptor. Earlier results have shown that it causes antinociception in different pain tests, but its effect is short-lasting. The purpose of the present study was to investigate the antinociceptive potency of continuously administered endomorphin-1 on carrageenan-induced thermal hyperalgesia by means of a paw withdrawal test in awake rats. The possible interaction between endomorphin-1 and the C-terminal octapeptide of the novel endogenous peptide nocistatin (bPNP-3-8P) was examined in the same experimental set-up. Continuous administration of endomorphin-1 (0.1, 0.3, 1 or 2 microg/min for 60 min) did not influence the paw withdrawal latencies of the normal paws. On the inflamed side, endomorphin-1 dose-dependently decreased the thermal hyperalgesia during continuous administration. The cessation of administration resulted in a gradual decrease in the antinociceptive effect of endomorphin-1. bPNP-3-8P (0.003-30 microg, administered cumulatively) significantly decreased the heat hyperalgesia at higher doses (3 and 30 microg). Continuous administration of bPNP-3-8P (0.03, 0.1 and 1 microg/min) did not potentiate the antinociceptive effect of endomorphin-1; instead, it even shortened the duration of its effect. The results demonstrate that continuous administration of endomorphin-1 is an effective method of inhibiting thermal hyperalgesia in rats. Furthermore, the fragment bPNP-3-8P itself has low antinociceptive potency and does not potentiate the antinociceptive effect of endomorphin-1 under these circumstances. 相似文献
292.
293.
Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version 下载免费PDF全文
V. Kanti A. Messenger G. Dobos P. Reygagne A. Finner A. Blumeyer M. Trakatelli A. Tosti V. del Marmol B.M. Piraccini A. Nast U. Blume‐Peytavi 《Journal of the European Academy of Dermatology and Venereology》2018,32(1):11-22
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80% Caucasian men and 42% of women. Patients afflicted with androgenetic alopecia may undergo significant impairment of quality of life. The European Dermatology Forum (EDF) initiated a project to develop evidence‐based guidelines for the treatment of androgenetic alopecia. Based on a systematic literature research the efficacy of the currently available therapeutic options was assessed and therapeutic recommendations were passed in a consensus conference. The purpose of the guideline is to provide dermatologists with an evidence‐based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia. 相似文献
294.
Rajpal S. Kashyap Karen M. Dobos John T. Belisle Hemant J. Purohit Nitin H. Chandak Girdhar M. Taori Hatim F. Daginawala 《Clinical and Vaccine Immunology : CVI》2005,12(6):752-758
Tuberculous meningitis (TBM) is the most common form of chronic infection of the central nervous system. Despite the magnitude of the problem, the general diagnostic outlook is discouraging. Specifically, there is no generally accepted early confirmative diagnosis protocol available for TBM. Various Mycobacterium tuberculosis antigens are now recognized as potential markers for diagnosis of TBM. However, their presence remains questionable, and many of these antigens are reported in the blood but not in the cerebrospinal fluid (CSF). This study identifies a specific protein marker in CSF which will be useful in early diagnosis of TBM. We have demonstrated the presence of a 30-kDa protein band in CSF of 100% (n = 5) of confirmed and 90% (n = 138) of suspected TBM patients out of 153 TBM patients. The 30-kDa band was excised from the gel, destained extensively, and digested with trypsin. The resulting peptides were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Partially purified proteins from CSF samples of TBM were analyzed by two-dimensional polyacrylamide gel electrophoresis and Western blotting. Immunoblotting and enzyme-linked immunosorbent assay (ELISA) were performed to confirm the presence of proteins in the 30-kDa protein band. The antigen 85 (Ag 85) complex was detected in CSF of TBM patients by indirect ELISA using antibodies against Ag 85 complex. The results of this study showed the 30-kDa protein band contained MTB proteins Rv3804c (Ag85A) and Rv1886c (Ag 85B), both members of the Ag85 complex. This was also confirmed by using immunotechniques such as indirect ELISA and the dot immunobinding assay. Detection of Ag85 complex was observed in CSF of 89% (71 out of 80) of suspected TBM patients that were 30-kDa protein positive. The observed 30-kDa protein in the CSF is comprised of the MTB Ag85 complex. This protein was earlier reported to be present in the blood of patients with extra-central nervous system tuberculosis. Therefore, this finding suggests that this protein can be used as a molecular marker for any type of tuberculous infection. It also provides a more sensitive immunoassay option for the early and confirmatory diagnosis of TBM. 相似文献
295.